Home › Markets › Health Care › DCOY

Decoy Therapeutics Inc. (DCOY)

DCOY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.24
-13.29% on the day
Market cap
$3.0M
Nano cap
Revenue
No annual revenue filed since the period ending 2022-12-31
Net income
No annual revenue filed since the period ending 2022-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerDCOY on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2015
SEC CIK0001615219
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2022-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12026-10-07
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-08-12
Latest current report8-K2026-09-23
Latest proxyDEF 14A2026-08-04

Source: SEC EDGAR submissions feed, 741 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ONCOOnconetix Inc.$0.5550-6.00%$2.9M
XRTXXORTX Therapeutics Inc. Common Shares$1.68-2.33%$3.1M
PRFXPRF Technologies Ltd.$0.8180-4.88%$2.9M
MBIOMustang Bio Inc.$0.3768-8.63%$2.9M
HCWBHCW Biologics Inc.$1.26-14.87%$2.8M
APVOAptevo Therapeutics Inc.$1.73-5.79%$3.1M
KAPAKairos Pharma Ltd.$0.8287-0.40%$2.8M
RDHLRedhill Biopharma Ltd.$0.5150-3.45%$3.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier